Skip to content
Screener

Labcorp Holdings LH Q3 2025 earnings

Reported October 28, 2025 · Before market open

Revenue$3.6BBeat by $5.8M
EPS$4.18Beat by $0.05
Revenue estimate$3.6B
EPS estimate$4.13

Next report

Oct 27, 2026 (in 2 months)
Revenue estimate$3.8B
EPS estimate$4.63

Financials

Q3 2025

Income statement

See full
Revenue$3.6B+8.6%
Gross profit$1.0B+13.3%
Operating income$396.6M+56.1%
Net income$261.1M+54.2%
EPS (diluted)$3.12+56.0%

Balance sheet

See full
Cash & equivalents$598.1M-60.6%
Total debt$6.0B-4.6%
Total equity$8.7B+6.4%
Total assets$18.3B-1.9%

Cash flow

See full
Operating cash flow$387.2M+39.6%
CapEx$106.7M-7.9%
Free cash flow$280.5M+73.7%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$23.85B+26.9%
Enterprise value$29.29B+24.1%
P/E27.9×—
P/S1.7×+0.3×

Profitability

See full
Gross margin28.4%+0.5pp
Operating margin9.7%—
Net margin6.2%—
FCF margin10%+3.4pp

Returns & leverage

See full
Return on equity10.1%—
Debt / equity0.7×-0.1×
Current ratio1.6×+0.1×

Segments

By segment

See full
Diagnostics$2.8B+8.5%
Biopharma Laboratory Services$799.1M—

FAQ

When did Labcorp Holdings report Q3 2025 earnings?
Labcorp Holdings (LH) reported Q3 2025 earnings on October 28, 2025 before market open.
What were Labcorp Holdings's Q3 2025 revenue and EPS?
Labcorp Holdings reported revenue of $3.6B and eps of $4.18 for Q3 2025.
Did Labcorp Holdings beat estimates in Q3 2025?
Revenue beat the consensus estimate of $3.6B by $5.8M. EPS beat the consensus estimate of $4.13 by $0.05.
How did Labcorp Holdings's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 8.6% from $3.3B a year earlier and eps grew 19.4% from $3.50.
Where can I find Labcorp Holdings's Q3 2025 SEC filings?
You can read the 8-K earnings release (0000920148-25-000093) and the 10-Q periodic report (0000920148-25-000096) directly on SEC EDGAR. The filing index links above go to sec.gov.